One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-131676
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 8 |
Affiliation: Roswell Park Cancer Institute, Saint Louis University, Froedtert Hospital, Hôpital Saint-Louis, Université Paris Cité, City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, Onconova Therapeutics (United States), Rush University Medical Center, Icahn School of Medicine at Mount Sinai, Cancer Center of KansasPhase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
